*Available for weight management patients How Henry Works Get started with no insurance required
52 (4): 36974 Bron AJ, Tiffany JM, Gouveia SM, et al
Tirzepatide (dual GIP + GLP-1 agonist) Tirzepatide targets two pathways (GIP and GLP-1), which is one reason it has shown greater average weight reduction in multiple studies compared with GLP-1-only options
The nutrition experience is built around common GLP-1 follow-through needs food, protein, fiber, water, symptoms, and medication context rather than only a generic calorie-tracking workflow or macro-coaching system
,
There were no notable overall differences by ethnicity, socioeconomic markers, smoking status, or level of alcohol consumption